ADVANCING OPHTHALMOLOGY INNOVATION
We at MellingMedical are impressed by Iantrek for their pioneering approach in ophthalmology, which has expanded options in glaucoma care. Founded by Dr. Sean Ianchulev, a visionary in the ophthalmic field, Iantrek is driving innovation with their unique Bio-Interventional Ophthalmic Surgery (BIOS) technology. Unlike conventional glaucoma procedures that introduce permanent metal or plastic implants, Iantrek employs allogeneic biotissue—natural donor tissue—to fortify the eye’s drainage systems, potentially lowering the risk of complications such as long-term inflammation or implant migration.
Iantrek’s advancements, such as the AlloFlo™ Uveo, a biologic-tissue-based, hardware-free solution launched in October 2025, aim to transform how the uveoscleral pathway in the eye is treated, a focus area that many modern MIGS devices overlook. Their C. Rex™ micro-interventional system offers another innovative solution by performing 360-degree circumferential goniotomy, which is pivotal for enhancing trabecular outflow. The AquaLumen device augments surgical visualization, ensuring greater precision and accessibility during procedures.
Clinical trials published in Ophthalmology Science in 2025 have showcased notable results, reporting a 34% average reduction in intraocular pressure over two years, with more than 60% of patients easing their dependence on regular eye drops. In support of its U.S. commercial growth, Iantrek secured $42 million in Series C funding as of August 2025.
ENABLING FEDERAL HEALTHCARE ACCESS
MellingMedical is committed to facilitating access to pioneering ophthalmic solutions for federal healthcare systems, including those that serve veterans. By providing clear and compliant procurement channels, we ensure that essential innovations, such as those by Iantrek, are available to federal healthcare professionals. This promotes enhanced patient care without the burden of navigating complex supply systems.
Through structured procurement strategies applied as part of our contractual relationship, we streamline the process of integrating Iantrek’s unique technologies into the federal healthcare landscape. Our role is to ensure these advanced tools are accessible, offering federal healthcare facilities the opportunity to incorporate cutting-edge treatments into their practices, optimizing patient outcomes without compromising compliance standards.